Prophylactic Ribonucleic Acid Vaccines to Combat RNA Viral Infections in Humans
Vaccines have evolved as widely applicable and available prophylaxes against infectious diseases. Advances in ribonucleic acid technologies revolutionized the biopharmaceutical field of vaccine manufacturing. Numerous novel mRNA-based vaccines that have been approved by the United States and Europea...
Guardado en:
| Autores principales: | , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/84092 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Prophylactic Ribonucleic Acid Vaccines to Combat RNA Viral Infections in Humans
- Ribonucleic acid (RNA) virus and coronavirus in Google Dataset Search: their scope and epidemiological correlation
- Human Papillomavirus Prophylactic Vaccines and Alternative Strategies for Prevention
- Introductory Chapter: RNA Drugs Development and Commercialization
- Natural Phenolic Acids and Their Derivatives against Human Viral Infections
- Diagnostic Applications for RNA-Seq Technology and Transcriptome Analyses in Human Diseases Caused by RNA Viruses
- Introductory Chapter: Applications of RNA-Seq Diagnostics in Biology and Medicine